BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

591 related articles for article (PubMed ID: 18940300)

  • 21. Direct aortic access for transcatheter self-expanding aortic bioprosthetic valves implantation.
    Bruschi G; de Marco F; Botta L; Cannata A; Oreglia J; Colombo P; Barosi A; Colombo T; Nonini S; Paino R; Klugmann S; Martinelli L
    Ann Thorac Surg; 2012 Aug; 94(2):497-503. PubMed ID: 22633495
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Risk of acute kidney injury in patients with severe aortic valve stenosis undergoing transcatheter valve replacement.
    Aregger F; Wenaweser P; Hellige GJ; Kadner A; Carrel T; Windecker S; Frey FJ
    Nephrol Dial Transplant; 2009 Jul; 24(7):2175-9. PubMed ID: 19211648
    [TBL] [Abstract][Full Text] [Related]  

  • 23. One-year outcomes of cohort 1 in the Edwards SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve.
    Thomas M; Schymik G; Walther T; Himbert D; Lefèvre T; Treede H; Eggebrecht H; Rubino P; Colombo A; Lange R; Schwarz RR; Wendler O
    Circulation; 2011 Jul; 124(4):425-33. PubMed ID: 21747054
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transapical aortic valve implantation in 175 consecutive patients: excellent outcome in very high-risk patients.
    Pasic M; Unbehaun A; Dreysse S; Drews T; Buz S; Kukucka M; Mladenow A; Gromann T; Hetzer R
    J Am Coll Cardiol; 2010 Aug; 56(10):813-20. PubMed ID: 20797496
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transapical aortic valve implantation in high-risk patients with severe aortic valve stenosis.
    D'Onofrio A; Fusari M; Abbiate N; Zanchettin C; Bianco R; Fabbri A; Salvador L; Polesel E; Biglioli P; Gerosa G
    Ann Thorac Surg; 2011 Nov; 92(5):1671-7. PubMed ID: 22051264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcatheter aortic valve implantation for the treatment of severe symptomatic aortic stenosis in patients at very high or prohibitive surgical risk: acute and late outcomes of the multicenter Canadian experience.
    Rodés-Cabau J; Webb JG; Cheung A; Ye J; Dumont E; Feindel CM; Osten M; Natarajan MK; Velianou JL; Martucci G; DeVarennes B; Chisholm R; Peterson MD; Lichtenstein SV; Nietlispach F; Doyle D; DeLarochellière R; Teoh K; Chu V; Dancea A; Lachapelle K; Cheema A; Latter D; Horlick E
    J Am Coll Cardiol; 2010 Mar; 55(11):1080-90. PubMed ID: 20096533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [POL-TAVI First--Polish report on transcatheter aortic valve implantation (TAVI) of Edwards-Sapien prosthesis in the first 19 high risk patients with severe aortic stenosis and comorbidities].
    Zembala M; Wilczek K; Przybylski R; Chodór P; Nadziakiewicz P; Krasoń M; Sadowski J; Dudek D; Kapelak B; Forysz D; Witkowski A; Demkow M; Chmielak Z; Kuśmierski K; Juraszyński Z; Bochenek A; Cisowski M; Trusz-Gluza M; Buszman P; Woś S; Kalarus Z; Poloński L; Gasior M; Opolski G; Ruzyłło W
    Kardiol Pol; 2009 Aug; 67(8):936-40. PubMed ID: 19784896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Exercise capacity in patients with severe symptomatic aortic stenosis before and six months after transcatheter aortic valve implantation.
    Bagur R; Rodés-Cabau J; Dumont E; Larochellière RD; Doyle D; Bertrand OF; Côté M; Poirier P; Pibarot P
    Am J Cardiol; 2011 Jul; 108(2):258-64. PubMed ID: 21545988
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High-risk aortic valve replacement: are the outcomes as bad as predicted?
    Grossi EA; Schwartz CF; Yu PJ; Jorde UP; Crooke GA; Grau JB; Ribakove GH; Baumann FG; Ursumanno P; Culliford AT; Colvin SB; Galloway AC
    Ann Thorac Surg; 2008 Jan; 85(1):102-6; discussion 107. PubMed ID: 18154791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcatheter valve-in-valve implantation for deteriorated aortic bioprosthesis: initial clinical results and follow-up in a series of high-risk patients.
    Wilbring M; Sill B; Tugtekin SM; Alexiou K; Simonis G; Matschke K; Kappert U
    Ann Thorac Surg; 2012 Mar; 93(3):734-41. PubMed ID: 22304904
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience.
    Cribier A; Eltchaninoff H; Tron C; Bauer F; Agatiello C; Nercolini D; Tapiero S; Litzler PY; Bessou JP; Babaliaros V
    J Am Coll Cardiol; 2006 Mar; 47(6):1214-23. PubMed ID: 16545654
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical profile, treatment assignment and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacement.
    Ben-Dor I; Pichard AD; Satler LF; Okubagzi P; Torguson R; Xue Z; Kaneshige K; Goldstein SA; Syed AI; Li Y; Lemesle G; Maluenda G; Collins SD; Wang Z; Suddath WO; Kent KM; Lindsay J; Waksman R
    Am J Cardiol; 2010 Mar; 105(6):857-61. PubMed ID: 20211332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transapical aortic valve implantation in patients requiring redo surgery.
    Walther T; Falk V; Borger MA; Kempfert J; Ender J; Linke A; Schuler G; Mohr FW
    Eur J Cardiothorac Surg; 2009 Aug; 36(2):231-4; discussion 234-5. PubMed ID: 19324566
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Percutaneous aortic valve replacement - initial experience and results].
    Olsen LK; Engstrøm T; Wachtell K; Kristensen T; Hassager C; Ihlemann N; Møller JE; Andersen LW; Olsen PS; Søndergaard L
    Ugeskr Laeger; 2009 Apr; 171(15):1289-93. PubMed ID: 19416621
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and treatment of procedural cardiovascular complications associated with trans-arterial and trans-apical interventional aortic valve implantation in 412 consecutive patients.
    Lange R; Bleiziffer S; Piazza N; Mazzitelli D; Hutter A; Tassani-Prell P; Laborde JC; Bauernschmitt R
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1105-13. PubMed ID: 21515069
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alternative approaches for trans-catheter self-expanding aortic bioprosthetic valves implantation: single-center experience.
    Bruschi G; De Marco F; Fratto P; Oreglia J; Colombo P; Botta L; Klugmann S; Martinelli L
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):e151-8. PubMed ID: 21371900
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcatheter aortic valve implantation: time to expand?
    Walther T; Chu MW; Mohr FW
    Curr Opin Cardiol; 2008 Mar; 23(2):111-6. PubMed ID: 18303522
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transapical minimally invasive aortic valve implantation: multicenter experience.
    Walther T; Simon P; Dewey T; Wimmer-Greinecker G; Falk V; Kasimir MT; Doss M; Borger MA; Schuler G; Glogar D; Fehske W; Wolner E; Mohr FW; Mack M
    Circulation; 2007 Sep; 116(11 Suppl):I240-5. PubMed ID: 17846311
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transapical approach for sutureless stent-fixed aortic valve implantation: experimental results.
    Walther T; Dewey T; Wimmer-Greinecker G; Doss M; Hambrecht R; Schuler G; Mohr FW; Mack M
    Eur J Cardiothorac Surg; 2006 May; 29(5):703-8. PubMed ID: 16600616
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Surgical management of aortic valve disease in the elderly: A retrospective comparative study of valve choice using propensity score analysis.
    Accola KD; Scott ML; Palmer GJ; Thompson PA; Sand ME; Suarez-Cavalier JE; Bott JN; Ebra G
    J Heart Valve Dis; 2008 Jul; 17(4):355-64; discussion 365. PubMed ID: 18751463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.